WST
West Pharmaceutical Services, Inc.
Stock
$364.98−0.03 (−0.01%)Close Oct 2, 2026
- Revenue, 2025
- $3.1B
- YoY, 2025
- +6.3%
- 5-year CAGR
- +7.4%
- 10-year CAGR
- +8.2%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $3.1B | +6.3% |
| 2024 | $2.9B | −1.9% |
| 2023 | $2.9B | +2.2% |
| 2022 | $2.9B | +2.0% |
| 2021 | $2.8B | +31.9% |
| 2020 | $2.1B | +16.7% |
| 2019 | $1.8B | +7.1% |
| 2018 | $1.7B | +7.4% |
| 2017 | $1.6B | +6.0% |
| 2016 | $1.5B | +7.8% |
| 2015 | $1.4B | −1.5% |
| 2014 | $1.4B | +3.9% |
| 2013 | $1.4B | +8.1% |
| 2012 | $1.3B | +6.2% |
| 2011 | $1.2B | +7.9% |
| 2010 | $1.1B | +4.6% |
| 2009 | $1.1B | +0.4% |
| 2008 | $1.1B | — |